Belluscura (FRA:9VQ) ROE % Adjusted to Book Value : -25.95% (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Belluscura ROE % Adjusted to Book Value?

Belluscura's ROE % for the quarter that ended in Jun. 2023 was -55.80%. Belluscura's PB Ratio for the quarter that ended in Jun. 2023 was 2.15. Belluscura's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2023 was -25.95%.

Belluscura ROE % Adjusted to Book Value Historical Data

The historical data trend for Belluscura's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Belluscura ROE % Adjusted to Book Value Chart

Belluscura Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

ROE % Adjusted to Book Value

-5.48

-7.96

Belluscura Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial				-9.46	-3.31	-7.72	-6.88	-25.95

Competitive Comparison of Belluscura's ROE % Adjusted to Book Value

For the Medical Devices subindustry, Belluscura's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Belluscura's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Belluscura's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Belluscura's ROE % Adjusted to Book Value falls into.

Belluscura ROE % Adjusted to Book Value Calculation

Belluscura's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2022 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-37.50%	/	4.71
	=	-7.96%

Belluscura's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-55.80%	/	2.15
	=	-25.95%

Belluscura ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Belluscura's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Belluscura (FRA:9VQ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Belluscura PLC (FRA:9VQ) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

BELL:UK

Address

15 Fetter Lane, Holborn, London, GBR, EC4A 1BW

Website

https://www.belluscura.com

Belluscura PLC is a medical device company. Its first product, the X-PLOR, is a lightweight FDA-cleared portable oxygen concentrator designed to replace larger, metal oxygen tanks and heavier portable oxygen concentrator devices. The X-PLO2R weighs less than 1.5kg (3.25 lbs) and it is the first modular portable oxygen concentrator it will generate more oxygen by weight than any other FDA-cleared POC in its class. It either owns or exclusively licenses a total of 26 patents and applications relating to oxygen enrichment devices and treatments.

Belluscura (FRA:9VQ) Headlines

No Headlines